Evidence map›Paper›PMID 36365470›Full record

ArticlePolymers2022

Cyclodextrins and Their Polymers Affect the Lipid Membrane Permeability and Increase Levofloxacin's Antibacterial Activity In Vitro.

Anna A Skuredina, Anastasia S Tychinina, Irina M Le-Deygen, Sergey A Golyshev, Tatiana Yu Kopnova, Nikolay T Le, Natalya G Belogurova, Elena V Kudryashova

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Cyclodextrins in action: ModulatingBiotechnology reports (Amsterdam, Netherlands) · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anna A SkuredinaChemistry Department, Lomonosov MSU, 119991 Moscow, Russia.
Anastasia S TychininaChemistry Department, Lomonosov MSU, 119991 Moscow, Russia.
Irina M Le-DeygenChemistry Department, Lomonosov MSU, 119991 Moscow, Russia.ORCID 0000-0002-6366-4491
Sergey A GolyshevBelozersky Institute of Physico-Chemical Biology, Lomonosov MSU, 119991 Moscow, Russia.
Tatiana Yu KopnovaChemistry Department, Lomonosov MSU, 119991 Moscow, Russia.ORCID 0000-0001-5196-5863
Nikolay T LeFaculty of Physics, Lomonosov MSU, 119991 Moscow, Russia.
Natalya G BelogurovaChemistry Department, Lomonosov MSU, 119991 Moscow, Russia.
Elena V KudryashovaChemistry Department, Lomonosov MSU, 119991 Moscow, Russia.
Lomonosov Moscow State University · RU

Funding

Russian Foundation for Basic Research 21-33-70035Russian Science Foundation 22-24- 501 00604
6 · The paper itself

Abstract

Cyclodextrins (CDs) are promising drug carriers that are used in medicine. We chose CDs with different substituents (polar/apolar, charged/neutral) to obtain polymers (CDpols) with different properties. CDpols are urethanes with average Mw of ~120 kDa; they form nanoparticles 100-150 nm in diameter with variable ζ-potential. We studied the interaction of CD and CDpols with model (liposomal) and bacterial membranes. Both types of CD carriers cause an increase in the liposomal membrane permeability, and for polymers, this effect was almost two times stronger. The formation of CD/CDpols complexes with levofloxacin (LV) enhances LV's antibacterial action 2-fold in vitro on five bacterial strains. The most pronounced effect was determined for LV-CD complexes. LV-CDs and LV-CDpols adsorb on bacteria, and cell morphology influences this process dramatically. According to TEM studies, the rough surface and proteinaceous fimbria of Gram-negative

Indexed as

antibacterial activitycyclodextrinlevofloxacinliposomespectroscopy

Identifiers

PMID36365470
PMCPMC9654586
OpenAlexW4307263362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.